InvestorsHub Logo
Followers 14
Posts 599
Boards Moderated 0
Alias Born 07/05/2017

Re: None

Sunday, 08/29/2021 11:21:09 AM

Sunday, August 29, 2021 11:21:09 AM

Post# of 429232
Let me get this straight. I see a lot of folks across a variety of forums this morning who are pissed off and it’s back to the $4’s or less for good? The company is a failure? Again? And why is that exactly? Because the wonder drug we have in V, which was never designed to be anti-viral was confirmed to not prevent Covid? That’s it for Prepare IT 1. Doesn’t prevent Covid. Got it. I learned that last May when I shared that I’ve been on V for 3 years and tested positive for Covid, with NO symptoms. That V doesn’t prevent Covid is what some expected, while the rest of us remained hopeful of the unknown. That they couldn’t get the presentation time right, so it’s game over again and KM’s trend of mismanagement continues? Whatever. It is frustrating they continue to make simple mistakes even when alerted prior.

Prepare IT 2 is pretty much a larger Cardiolink-9 study, yes? If that’s not stat sig then close the door on V as a Covid therapeutic. Until then it’s just more noise re Prepare IT 1. Let’s forget about the Germany launch coming up or the fact that Lizzy confirmed it was PFE who approached HLS for the Canada partnership. The PFE tidbit is, to me, by far the biggest tell of BP’s interest in V by BP. Let’s forget this weekend showed a huge risk reduction of suffering a second heart attack for anyone who had one prior, like many friends/family of mine who I’m reaching out to today to ensure I do my part in educating them of this finding. Karim has been in the role for less than a month. He has to do better, yes. He has to hold folks accountable and most importantly he needs to leverage his BP relationships and get this thing sold ASAP. Until then or unless we get movement in the DE case our US scripts will continue to erode and sentiment will continue to be sour. I wish I had a fast fwd button on this thing.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News